HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NIR photothermal therapy using polyaniline nanoparticles.

Abstract
Developing a biocompatible and efficient photothermal coupling agent with appropriate size is a prerequisite for the development of near-infrared (NIR) light-induced photothermal therapy (PTT). In the present study, polyaniline nanoparticles (PANPs) with a size of 48.5 ± 1.5 nm were fabricated and exhibited excellent dispersibility in water by a hydrothermal method and further surface functionalization by capping with F127. The developed F127-modified PANPs (F-PANPs) had a high molar extinction coefficient of 8.95 × 10(8) m(-1) cm(-1), and high NIR photothermal conversion efficiency of 48.5%. Furthermore, combined with NIR irradiation at 808 nm and injection of F-PANP samples, in vivo photothermal ablation of tumor with excellent treatment efficacy was achieved. In vitro transmission electron microscopy (TEM) images of cells, methyl thiazolyl tetrazolium (MTT) assay, histology, and hematology studies revealed that the F-PANPs exhibit low toxicity to living systems. Therefore, F-PANPs could be used as PTT agents for ablating cancer, and the concept of developing polyaniline-based nanoparticles can serve as a platform technology for the next generation of in vivo PTT agents.
AuthorsJing Zhou, Zhigao Lu, Xingjun Zhu, Xuejiao Wang, Yi Liao, Zhanfang Ma, Fuyou Li
JournalBiomaterials (Biomaterials) Vol. 34 Issue 37 Pg. 9584-92 (Dec 2013) ISSN: 1878-5905 [Electronic] Netherlands
PMID24044996 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Aniline Compounds
  • polyaniline
Topics
  • Aniline Compounds (chemistry, therapeutic use)
  • Animals
  • Colon (drug effects, pathology)
  • Colonic Neoplasms (pathology, therapy)
  • HCT116 Cells
  • Humans
  • Hyperthermia, Induced (methods)
  • Infrared Rays
  • Mice
  • Nanoparticles (chemistry, therapeutic use)
  • Phototherapy (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: